Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 9Terminated 3Recruiting 1Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Myeloid 1Lymphoid 1Classical hematology 1

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Myelodysplastic Syndromes 1Leukemia, Myelogenous, Chronic, BCR-ABL Positive 1Leukemia, Biphenotypic, Acute 1Hematologic Neoplasms 1Anemia, Refractory, with Excess of Blasts 1

Interventions

Cyclophosphamide 12fludarabine 11fludarabine phosphate 8Tacrolimus 8Melphalan 8Whole-Body Irradiation 7Mycophenolic Acid 7Thiotepa 6Imatinib Mesylate 6nilotinib 5Granulocyte Colony-Stimulating Factor 5Dasatinib 5Busulfan 5asciminib 4Mesna 4venetoclax 3ponatinib 3bosutinib 3Sirolimus 3Peripheral Blood Stem Cell Transplantation 3thymoglobulin 2ruxolitinib 2blinatumomab 2Patient Reported Outcome Measures 2Filgrastim 2Antilymphocyte Serum 2selinexor 1plerixafor 1Triamcinolone 1Transplantation 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Active not recruiting × Leukemia, Myelogenous, Chronic, BCR-ABL Positive × Cord Blood Stem Cell Transplantation × Clear all
NCT03399773 2025-08-26

Infusion of Expanded Cord Blood Cells in Addition to Single Cord Blood Transplant in Treating Patients With Acute Leukemia, Chronic Myeloid Leukemia, or Myelodysplastic Syndromes

Fred Hutchinson Cancer Center

Phase 2 Active not recruiting
31 enrolled
Classical hematologyLymphoidMyeloidOther hematologic neoplasm

Anemia, Refractory, with Excess of Blasts, Myelodysplastic Syndromes, Leukemia, Biphenotypic, Acute, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Hematologic Neoplasms, Precursor Cell Lymphoblastic Leukemia-Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡